Ultra Petroleum Provides Operational and Financial Update
Sep 18, 2017 20:30 pm UTC| Business
HOUSTON, Sept. 18, 2017 -- Ultra Petroleum Corp. (NASDAQ:UPL) announces the following operational and financial updates: Operational Update Production As of September 15, 2017, Ultra’s total net daily production...
PLx Pharma Present at the Sidoti & Company Fall 2017 Conference
Sep 18, 2017 20:30 pm UTC| Business
HOUSTON, Sept. 18, 2017 -- PLx Pharma Inc. (NASDAQ:PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company focused on commercializing two patent-protected products, Aspertec™ 325 mg and Aspertec™...
AMREP Announces Appointments of Chief Executive Officer and Chief Financial Officer
Sep 18, 2017 20:30 pm UTC| Business
PLYMOUTH MEETING, Pa., Sept. 18, 2017 -- AMREP Corporation (the “Company”) (NYSE:AXR) today announced that Christopher Vitale has been appointed as President and Chief Executive Officer of AMREP. In addition, James...
MB Financial, Inc. Approves Dividend on its Series A Preferred Stock
Sep 18, 2017 20:30 pm UTC| Business
CHICAGO, Sept. 18, 2017 -- MB Financial, Inc. (the “Company”), (Nasdaq:MBFI) announced today that its Board of Directors has declared a quarterly cash dividend of $0.50 per share on its Perpetual, Non-Cumulative...
Sep 18, 2017 20:30 pm UTC| Business
HAMILTON, Bermuda, Sept. 18, 2017 -- Blue Capital Reinsurance Holdings Ltd. (NYSE:BCRH); ("Blue Capital") has declared a quarterly dividend of $0.30 per common share, which is payable on or before October 13, 2017 to...
$1.6 million NSF grant to advance understanding of ‘amorphous’ materials
Sep 18, 2017 20:21 pm UTC| Business
Rolla, Mo., Sept. 18, 2017 -- A physics professor at Missouri University of Science and Technology will lead a four-year effort to spur research, development and commercial adoption of a new class of oxide...
Aquinox to Present at 2017 Cantor Fitzgerald Global Healthcare Conference
Sep 18, 2017 20:15 pm UTC| Business
VANCOUVER, British Columbia, Sept. 18, 2017 -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of...